Friday, Aug 14, 2026

"chronic-metabolic-diseases"

Dr Reddy’s launches oral semaglutide biosimilar Obeda in India

This launch follows Dr Reddy's recent generic semaglutide injection launches in India and Canada, Dr Reddy's Laboratories Ltd (DRL) said in a statement

Latest News

ACB arrests Jagtial revenue inspector in Rs 30,000 bribe case

5 minutes ago
Startups must reach rural, remote areas, says Nirmala Sitharaman

7 hours ago
Karnataka Cabinet approves Sandhya Kiran cashless healthcare scheme for pensioners

9 hours ago
Naidu directs plans to boost power generation, cut electricity costs in AP

9 hours ago
Editorial: Indo-US space cooperation gains strategic depth

9 hours ago
Can marital discord between colleagues invoke POSH Act: Allahabad HC

8 hours ago
SCBA chief condemns BCI directive against NALSAR graduates

10 hours ago
Telangana State Yoga Championship to be held in September

10 hours ago